Response to comments on "PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational study".

CHING-YAO YANGJIN-YUAN SHIH2026-04-132026-04-132026-04https://scholars.lib.ntu.edu.tw/handle/123456789/737103enResponse to comments on "PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational study".letter10.1016/j.jfma.2025.04.02840307152